Go to Course: https://www.coursera.org/learn/drug-commercialization
### Course Review: Drug Commercialization by UC San Diego As the pharmaceutical industry continues to grow and evolve, understanding the complex process of drug commercialization becomes essential for professionals in the field. Coursera’s course, **Drug Commercialization**, offered by the **University of California, San Diego** (UCSD) through the Skaggs School of Pharmacy and Pharmaceutical Sciences, is a comprehensive program designed to equip learners with the necessary tools and knowledge to navigate this multifaceted landscape. #### Overview The **Drug Commercialization** course features a series of lectures led by esteemed faculty members and industry experts, providing an unparalleled opportunity to learn from some of the top minds in drug development. Recorded on-site at UCSD, this course is structured to offer insights from those who are actively shaping the future of pharmaceuticals. The curriculum encompasses a variety of topics critical to the commercialization of pharmaceuticals, including pharmacoeconomics, marketing strategies, intellectual property considerations, and managed markets. By the end of the course, participants will have a better grasp of how to effectively bring a drug to market—an increasingly crucial skill set in today’s competitive healthcare environment. #### Syllabus Highlights The course is neatly organized into several key lectures, each delivered by experts in their respective fields: 1. **Pharmacoeconomics in Drug Development** – Dr. Jan Hirsch dives into the economic aspects of drug development, emphasizing the importance of value assessment in the commercialization process. 2. **Intellectual Property Strategy & BioSimilars** – Dr. Williams Ettouati addresses IP strategy, focusing on its significance in protecting innovations and leveraging biosimilars in the marketplace. 3. **Marketing Pharmaceuticals & Biotechnology Drugs** – Again led by Dr. Ettouati, this segment explores effective marketing strategies that resonate with both consumers and healthcare professionals. 4. **Managed Markets and Sales Strategy** – Dr. Doral Fredericks discusses how to navigate the complexities of managed care environments and optimize sales strategies. 5. **Strategic Alliances in Academia, Pharma, and Biotech** – Dr. Ettouati returns to analyze the importance of collaboration between different sectors for successful product development. 6. **Business Models and Portfolio Management** – Catherine Godrecka-Bareau, CFA, provides insights into strategic planning and resource allocation within pharmaceutical portfolios. 7. **Academic-Industry Partnership: "Various Models, Various Outcomes"** – Dr. Remi Brouard presents on different partnership strategies and their implications for innovation. 8. **From Startup to Success in Biotech** – Barry Quart, Pharm.D., concludes with an inspiring look at the journey from startup ventures to established biotech successes. #### Recommendation This course is a must for anyone operating within or entering the pharmaceutical and biotech sectors. It is particularly beneficial for: - **Pharmaceutical Professionals:** Those looking to deepen their understanding of drug commercialization will find the insights invaluable. - **Aspiring Entrepreneurs:** If you envision starting or growing a biotech company, the lessons on business models and partnerships are critical. - **Academics and Researchers:** Understanding how to navigate the commercialization process can enhance the impact of research initiatives. - **Marketing Specialists:** Those currently in or entering health marketing roles will gain knowledge on effective strategies and market dynamics. With its rigorous content and expert instructors, the **Drug Commercialization** course can provide you with a solid foundation in the necessary principles to make informed decisions in drug development and marketing. The blend of theoretical knowledge and practical insights makes this course a highly recommendable choice for both novices and seasoned professionals. In conclusion, I urge you to explore the **Drug Commercialization** course on Coursera, not just as an educational opportunity but as a stepping stone to enhance your career in the ever-evolving pharmaceutical landscape. Enroll today and empower yourself with the knowledge to succeed in drug commercialization!
Welcome!
Pharmacoeconomics in Drug Development, Jan Hirsch, Ph.D.Intellectual Property Strategy & BioSimilars, Williams Ettouati, Pharm.D.Marketing Pharmaceuticals & Biotechnology Drugs, Williams Ettouati, Pharm.D.Managed Markets and Sales Strategy, Doral Fredericks, Pharm.D., MBAStrategic Alliances in Academia, Pharma and Biotech, Williams Ettouati, Pharm. D.Business Models and Portfolio ManagementCatherine Godrecka-Bareau, CFA Director Strategy & Portfolio Management, Biosimilars, Merck
Academic Industry partnership "Various models, Various outcomes", Remi Brouard, M.D.From Start up to Success in Biotech, Barry Quart, Pharm.D.The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and stra
This course provided me to look to the pharmaceutical industry with a broader perspective. Thank you to the course organization and all the speakers.
interesting to learn about how the pharma industry works (as i'm not majoring in any related field) but i think you'd have to take the other 2 courses before this to gain a more complete understanding
The lecturers were clear in their explanations which were robust and comprehensive. Lecture material covered was interesting and informative.
Very helpful course if you`re planning to make a career in pharma. Gave a lot of insights on topics like drug commercialisation, regulatory, partnership, etc.
Overall a decent course. Content seems to be outdated as most of them are that of 2013 data. Pharma business model section was really informative and interesting.